Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat

Molecular Neurobiology

Volumn 54, Issue 8, 2017, Pages 6018-6031

  de Oliveira, Marcos Roberto ^a   Peres, Alessandra ^b,c   Gama, Clarissa Severino ^d,e   Bosco, Simone Morelo Dal ^b  

^a FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c CENTRO UNIVERSITÁRIO METODISTA IPA   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidant; Mitochondria; Nrf2; Paraquat; Pinocembrin

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 9; CYTOCHROME C; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARAQUAT; PINOCEMBRINE; PROTEIN BAX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR NRF2; FLAVANONE DERIVATIVE; NEUROPROTECTIVE AGENT; NFE2L2 PROTEIN, HUMAN;

ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN MITOCHONDRION; BRAIN PROTECTION; CONTROLLED STUDY; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME RELEASE; ERK1/2 NRF2 SIGNALING; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION REDUCTION REACTION; SH-SY5Y CELL LINE; SIGNAL TRANSDUCTION; CELL SURVIVAL; DRUG EFFECT; MAPK SIGNALING; METABOLISM; MITOCHONDRION; NERVE CELL; NEUROBLASTOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; DOWN-REGULATION; FLAVANONES; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; NEUROBLASTOMA; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; PARAQUAT;

EID: 84989208787     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-0135-5     Document Type: Article

References (76)

1. Rasul A, Millimouno FM, Ali Eltayb W, Ali M, Li J, Li X (2013) Pinocembrin: a novel natural compound with versatile pharmacological and biological activities. Biomed Res Int 2013:379850. doi:10.1155/2013/379850
2. Liu R, Gao M, Yang ZH, Du GH (2008) Pinocembrin protects rat brain against oxidation and apoptosis induced by ischemia-reperfusion both in vivo and in vitro. Brain Res 1216:104–115. doi:10.1016/j.brainres.2008.03.049
3. Soromou LW, Chu X, Jiang L, Wei M, Huo M, Chen N, Guan S, Yang X, Chen C, Feng H, Deng X (2012) In vitro and in vivo protection provided by pinocembrin against lipopolysaccharide-induced inflammatory responses. Int Immunopharmacol 14:66–74. doi:10.1016/j.intimp.2012.06.009
4. Zhou LT, Wang KJ, Li L, Li H, Geng M (2015) Pinocembrin inhibits lipopolysaccharide-induced inflammatory mediators production in BV2 microglial cells through suppression of PI3K/Akt/NF-κB pathway. Eur J Pharmacol 761:211–216. doi:10.1016/j.ejphar.2015.06.003
5. Czyżewska U, Siemionow K, Zaręba I, Miltyk W (2016) Proapoptotic activity of propolis and their components on human tongue squamous cell carcinoma cell line (CAL-27). PLoS One 11:e0157091. doi:10.1371/journal.pone.0157091
6. Xuan H, Wang Y, Li A, Fu C, Wang Y, Peng W (2016) Bioactive components of Chinese propolis water extract on antitumor activity and quality control. Evid Based Complement Alternat Med 2016:9641965. doi:10.1155/2016/9641965
7. Bremner PD, Meyer JJ (1998) Pinocembrin chalcone: an antibacterial compound from Helichrysum trilineatum. Planta Med 64:777
8. Massaro CF, Katouli M, Grkovic T, Vu H, Quinn RJ, Heard TA, Carvalho C, Manley-Harris M, Wallace HM, Brooks P (2014) Anti-staphylococcal activity of C-methyl flavanones from propolis of Australian stingless bees (Tetragonula carbonaria) and fruit resins of Corymbia torelliana (Myrtaceae). Fitoterapia 95:247–257. doi:10.1016/j.fitote.2014.03.024
9. Nina N, Quispe C, Jiménez-Aspee F, Theoduloz C, Feresín GE, Lima B, Leiva E, Schmeda-Hirschmann G (2015) Antibacterial activity, antioxidant effect and chemical composition of propolis from the Región del Maule, Central Chile. Molecules 20:18144–18167. doi:10.3390/molecules201018144
10. Gao M, Zhang WC, Liu QS, Hu JJ, Liu GT, Du GH (2008) Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur J Pharmacol 591:73–79. doi:10.1016/j.ejphar.2008.06.071
11. Gao M, Liu R, Zhu SY, Du GH (2008) Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats. J Asian Nat Prod Res 10:551–558. doi:10.1080/10286020801966955
12. Wang Y, Gao J, Miao Y, Cui Q, Zhao W, Zhang J, Wang H (2014) Pinocembrin protects SH-SY5Y cells against MPP+-induced neurotoxicity through the mitochondrial apoptotic pathway. J Mol Neurosci 53:537–545. doi:10.1007/s12031-013-0219-x
13. Meng F, Liu R, Gao M, Wang Y, Yu X, Xuan Z, Sun J, Yang F, Wu C, Du G (2011) Pinocembrin attenuates blood-brain barrier injury induced by global cerebral ischemia-reperfusion in rats. Brain Res 1391:93–101. doi:10.1016/j.brainres.2011.03.010
14. Shi LL, Chen BN, Gao M, Zhang HA, Li YJ, Wang L, Du GH (2011) The characteristics of therapeutic effect of pinocembrin in transient global brain ischemia/reperfusion rats. Life Sci 88:521–528. doi:10.1016/j.lfs.2011.01.011
15. Jin X, Liu Q, Jia L, Li M, Wang X (2015) Pinocembrin attenuates 6-OHDA-induced neuronal cell death through Nrf2/ARE pathway in SH-SY5Y cells. Cell Mol Neurobiol 35:323–333. doi:10.1007/s10571-014-0128-8
16. Lu SC (2013) Glutathione synthesis. Biochim Biophys Acta 1830:3143–3153. doi:10.1016/j.bbagen.2012.09.008
17. Costa SL, Silva VD, Dos Santos Souza C, Santos CC, Paris I, Muñoz P, Segura-Aguilar J (2016) Impact of plant-derived flavonoids on neurodegenerative diseases. Neurotox Res 30:41–52. doi:10.1007/s12640-016-9600-1
18. Das J, Ramani R, Suraju MO (2016) Polyphenol compounds and PKC signaling. Biochim Biophys Acta 1860:2107–2121. doi:10.1016/j.bbagen.2016.06.022
19. Kim J, Keum YS (2016) NRF2, a key regulator of antioxidants with two faces towards cancer. Oxidative Med Cell Longev 2016:2746457. doi:10.1155/2016/2746457
20. Wang H, Wang Y, Zhao L, Cui Q, Wang Y, Du G (2016) Pinocembrin attenuates MPP(+)-induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway. Neurosci Lett 612:104–109. doi:10.1016/j.neulet.2015.11.048
21. Hsu MJ, Sheu JR, Lin CH, Shen MY, Hsu CY (2010) Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim Biophys Acta 1800:290–296. doi:10.1016/j.bbagen.2009.08.003
22. Tait SW, Green DR (2012) Mitochondria and cell signalling. J Cell Sci 125:807–815. doi:10.1242/jcs.099234
23. Solá S, Morgado AL, Rodrigues CM (2013) Death receptors and mitochondria: two prime triggers of neural apoptosis and differentiation. Biochim Biophys Acta 1830:2160–2166. doi:10.1016/j.bbagen.2012.09.021
24. Green DR, Galluzzi L, Kroemer G (2014) Metabolic control of cell death. Science 345:1250256. doi:10.1126/science.1250256
25. Prozorovski T, Schneider R, Berndt C, Hartung HP, Aktas O (2015) Redox-regulated fate of neural stem progenitor cells. Biochim Biophys Acta 1850:1543–1554. doi:10.1016/j.bbagen.2015.01.022
26. Nicholls DG, Budd SL (1998) Neuronal excitotoxicity: the role of mitochondria. Biofactors 8:287–299
27. Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27:325–355
28. Bek T, Chair (2016) Mitochondrial dysfunction and diabetic retinopathy. Mitochondrion. doi:10.1016/j.mito.2016.07.011
29. de Oliveira MR (2016) Fluoxetine and the mitochondria: a review of the toxicological aspects. Toxicol Lett 258:185–191. doi:10.1016/j.toxlet.2016.07.001
30. de Oliveira MR, Jardim FR (2016) Cocaine and mitochondria-related signaling in the brain: a mechanistic view and future directions. Neurochem Int 92:58–66. doi:10.1016/j.neuint.2015.12.006
31. Atamna H, Mackey J, Dhahbi JM (2012) Mitochondrial pharmacology: electron transport chain bypass as strategies to treat mitochondrial dysfunction. Biofactors 38:158–166. doi:10.1002/biof.197
32. Arun S, Liu L, Donmez G (2016) Mitochondrial biology and neurological diseases. Curr Neuropharmacol 14:143–154. doi:10.2174/1570159X13666150703154541
33. Oliveira MR, Nabavi SF, Daglia M, Rastrelli L, Nabavi SM (2016) Epigallocatechin gallate and mitochondria—a story of life and death. Pharmacol Res 104:70–85. doi:10.1016/j.phrs.2015.12.027
34. de Oliveira MR, Nabavi SF, Manayi A, Daglia M, Hajheydari Z, Nabavi SM (2016) Resveratrol and the mitochondria: from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochim Biophys Acta 1860:727–745. doi:10.1016/j.bbagen.2016.01.017
35. de Oliveira MR, Jardim FR, Setzer WN, Nabavi SM, Nabavi SF (2016) Curcumin, mitochondrial biogenesis, and mitophagy: exploring recent data and indicating future needs. Biotechnol Adv 34:813–826. doi:10.1016/j.biotechadv.2016.04.004
36. de Oliveira MR, Nabavi SM, Braidy N, Setzer WN, Ahmed T, Nabavi SF (2016) Quercetin and the mitochondria: a mechanistic view. Biotechnol Adv 34:532–549. doi:10.1016/j.biotechadv.2015.12.014
37. Picard M, Wallace DC, Burelle Y (2016) The rise of mitochondria in medicine. Mitochondrion. doi:10.1016/j.mito.2016.07.003
38. Baltazar MT, Dinis-Oliveira RJ, de Lourdes Bastos M, Tsatsakis AM, Duarte JA, Carvalho F (2014) Pesticides exposure as etiological factors of Parkinson’s disease and other neurodegenerative diseases—a mechanistic approach. Toxicol Lett 230:85–103. doi:10.1016/j.toxlet.2014.01.039
39. Ruszkiewicz J, Albrecht J (2015) Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders. Neurochem Int 88:66–72. doi:10.1016/j.neuint.2014.12.012
40. de Oliveira MR, Schuck PF, Bosco SM (2016) Tanshinone I induces mitochondrial protection through an Nrf2-dependent mechanism in paraquat-treated human neuroblastoma SH-SY5Y cells. Mol Neurobiol. doi:10.1007/s12035-016-0009-x
41. Smythies J, De Iuliis A, Zanatta L, Galzigna L (2002) The biochemical basis of Parkinson’s disease: the role of catecholamine o-quinones: a review-discussion. Neurotox Res 4:77–81. doi:10.1080/10298420290007655
42. Calì T, Ottolini D, Brini M (2011) Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson’s disease. Biofactors 37:228–240. doi:10.1002/biof.159
43. Franco R, Li S, Rodriguez-Rocha H, Burns M, Panayiotidis MI (2010) Molecular mechanisms of pesticide-induced neurotoxicity: relevance to Parkinson’s disease. Chem Biol Interact 188:289–300. doi:10.1016/j.cbi.2010.06.003
44. Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M et al (2011) Rotenone, paraquat, and Parkinson’s disease. Environ Health Perspect 119:866–872. doi:10.1289/ehp.1002839
45. Kwon HJ, Heo JY, Shim JH, Park JH, Seo KS, Ryu MJ, Han JS, Shong M, Son JH, Kweon GR (2011) DJ-1 mediates paraquat-induced dopaminergic neuronal cell death. Toxicol Lett 202:85–92. doi:10.1016/j.toxlet.2011.01.018
46. Fukushima T, Yamada K, Isobe A, Shiwaku K, Yamane Y (1993) Mechanism of cytotoxicity of paraquat. I. NADH oxidation and paraquat radical formation via complex I. Exp Toxicol Pathol 45:345–349
47. Tsukamoto M, Tampo Y, Sawada M, Yonaha M (2002) Paraquat-induced oxidative stress and dysfunction of the glutathione redox cycle in pulmonary microvascular endothelial cells. Toxicol Appl Pharmacol 178:82–92
48. Blanco-Ayala T, Andérica-Romero AC, Pedraza-Chaverri J (2014) New insights into antioxidant strategies against paraquat toxicity. Free Radic Res 48:623–640. doi:10.3109/10715762.2014.899694
49. Moretto A, Colosio C (2011) Biochemical and toxicological evidence of neurological effects of pesticides: the example of Parkinson’s disease. Neurotoxicology 32:383–391. doi:10.1016/j.neuro.2011.03.004
50. de Oliveira MR, Ferreira GC, Schuck PF (2016) Protective effect of carnosic acid against paraquat-induced redox impairment and mitochondrial dysfunction in SH-SY5Y cells: role for PI3K/Akt/Nrf2 pathway. Toxicol in Vitro 32:41–54. doi:10.1016/j.tiv.2015.12.005
51. Moran JM, Gonzalez-Polo RA, Ortiz-Ortiz MA, Niso-Santano M, Soler G, Fuentes JM (2008) Identification of genes associated with paraquat-induced toxicity in SH-SY5Y cells by PCR array focused on apoptotic pathways. J Toxicol Environ Health A 71:1457–1467. doi:10.1080/15287390802329364
52. Ortiz-Ortiz MA, Morán JM, González-Polo RA, Niso-Santano M, Soler G, Bravo-San Pedro JM, Fuentes JM (2009) Nitric oxide-mediated toxicity in paraquat-exposed SH-SY5Y cells: a protective role of 7-nitroindazole. Neurotox Res 16:160–173. doi:10.1007/s12640-009-9065-6
53. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
54. Wang K, Zhu L, Zhu X, Zhang K, Huang B, Zhang J, Zhang Y, Zhu L, Zhou B, Zhou F (2014) Protective effect of paeoniflorin on Aβ25-35-induced SH-SY5Y cell injury by preventing mitochondrial dysfunction. Cell Mol Neurobiol 34:227–234. doi:10.1007/s10571-013-0006-9
55. Poderoso JJ, Carreras MC, Lisdero C, Riobó N, Schöpfer F, Boveris A (1996) Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys 328:85–92
56. de Oliveira MR, Moreira JC (2007) Acute and chronic vitamin A supplementation at therapeutic doses induces oxidative stress in submitochondrial particles isolated from cerebral cortex and cerebellum of adult rats. Toxicol Lett 173:145–150
57. de Oliveira MR, Ferreira GC, Schuck PF, Dal Bosco SM (2015) Role for the PI3K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Chem Biol Interact 242:396–406. doi:10.1016/j.cbi.2015.11.003
58. de Oliveira MR, Peres A, Ferreira GC, Schuck PF, Bosco SM (2016) Carnosic acid affords mitochondrial protection in chlorpyrifos-treated Sh-Sy5y cells. Neurotox Res. doi:10.1007/s12640-016-9620-x
59. O’Connell MA, Hayes JD (2015) The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic. Biochem Soc Trans 43:687–689. doi:10.1042/BST20150069
60. Cadenas E, Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222–230
61. Cadenas E (2004) Mitochondrial free radical production and cell signaling. Mol Asp Med 25:17–26
62. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13. doi:10.1042/BJ20081386
63. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658
64. de Oliveira MR, da Rocha RF, Moreira JC (2012) Increased susceptibility of mitochondria isolated from frontal cortex and hippocampus of vitamin A-treated rats to non-aggregated amyloid-β peptides 1-40 and 1-42. Acta Neuropsychiatr 24:101–108. doi:10.1111/j.1601-5215.2011.00588.x
65. de Oliveira MR (2015) Vitamin A and retinoids as mitochondrial toxicants. Oxidative Med Cell Longev 2015:140267. doi:10.1155/2015/140267
66. Espinosa-Diez C, Miguel V, Mennerich D, Kietzmann T, Sánchez-Pérez P, Cadenas S, Lamas S (2015) Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol 6:183–197. doi:10.1016/j.redox.2015.07.008
67. Dinkova-Kostova AT, Baird L, Holmström KM, Meyer CJ, Abramov AY (2015) The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics. Biochem Soc Trans 43:602–610. doi:10.1042/BST20150003
68. Dinkova-Kostova AT, Abramov AY (2015) The emerging role of Nrf2 in mitochondrial function. Free Radic Biol Med 88:179–188. doi:10.1016/j.freeradbiomed.2015.04.036
69. Gruber J, Fong S, Chen CB, Yoong S, Pastorin G, Schaffer S, Cheah I, Halliwell B (2013) Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. Biotechnol Adv 31:563–592. doi:10.1016/j.biotechadv.2012.09.005
70. Lu SC (2009) Regulation of glutathione synthesis. Mol Asp Med 30:42–59. doi:10.1016/j.mam.2008.05.005
71. Agarwal R, Shukla GS (1999) Potential role of cerebral glutathione in the maintenance of blood-brain barrier integrity in rat. Neurochem Res 24:1507–1514
72. Bakshi R, Zhang H, Logan R, Joshi I, Xu Y, Chen X, Schwarzschild MA (2015) Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release. Neurobiol Dis 82:574–579. doi:10.1016/j.nbd.2015.08.022
73. Mitra S, Siddiqui WA, Khandelwal S (2015) C-phycocyanin protects against acute tributyltin chloride neurotoxicity by modulating glial cell activity along with its anti-oxidant and anti-inflammatory property: a comparative efficacy evaluation with N-acetyl cysteine in adult rat brain. Chem Biol Interact 238:138–150. doi:10.1016/j.cbi.2015.06.016
74. Heales SJ, Davies SE, Bates TE, Clark JB (1995) Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 20:31–38
75. Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M, Maes M (2014) The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol 50:1059–1084. doi:10.1007/s12035-014-8705-x
76. Lash LH (2006) Mitochondrial glutathione transport: physiological, pathological and toxicological implications. Chem Biol Interact 163:54–67